炎症 - - 预防缺血性中风的新治疗目标
Sarah Gorey1,2, John J McCabe1,2,3, Peter J Kelly1,2,3
1Health Research Board (HRB) Stroke Clinical Trials Network Ireland (SCTNI), Dublin, Ireland.
Frontiers in stroke
|January 16, 2026
概括
重复性中风很常见,这凸显出需要更好的预防措施. 炎症在中风中起着关键作用,可能是使用血液生物标志物进行新疗法和风险评估的目标.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
背景情况:
- 在中风后经常出现复发性血管事件,这表明当前的二次预防策略存在差距.
- 炎症被认为是最初和复发性中风的因果因素.
- 血液中的炎症标志物显示出改善风险分层和指导密集预防疗法的潜力.
研究的目的:
- 审查炎症在中风和动脉样硬化的发病过程中的作用.
- 检查观察,遗传和临床试验中关于中风和心脏病中抗炎药物的证据.
- 讨论炎症生物标志物在中风管理中的实用性,并确定当前的挑战.
主要方法:
- 文献综述包括观察性研究,遗传分析和随机对照试验.
- 对脑血管和心血管疾病的抗炎疗法数据的分析.
- 综合关于炎症生物标志物在临床实践中的应用和限制的信息.
主要成果:
- 炎症是中风发病的一个重要因素,也是潜在的治疗点.
- 证据支持对二次中风预防的抗炎策略的调查.
- 炎症生物标志物可以帮助识别针对性干预的高风险患者.
结论:
- 针对炎症提供了一个有希望的途径,以改善二次中风预防.
- 炎症生物标志物在风险分层和患者管理方面具有潜在的临床应用.
- 需要进一步的研究来解决关于中风护理炎症的不确定性和争议.
相关概念视频
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Inflammation
61.7K
Overview
61.7K
Atherosclerosis IV: Nursing Management
369
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
369
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248


